Fd. Kolodgie et al., ESTRADIOL ATTENUATES DIRECTED MIGRATION OF VASCULAR SMOOTH-MUSCLE CELLS IN-VITRO, The American journal of pathology, 148(3), 1996, pp. 969-976
Although the cardiovascular benefits of the hormone estrogen are at le
ast, in part, mediated by its antiproliferative effect on vascular smo
oth muscle, its action on the migration of these cells is unknown. To
explore this relationship, female rat aortic smooth muscle cells were
grown in hormone-free medium, and the effect of various concentrations
of beta-estradiol on directed cellular migration was measured in vitr
o using a microwell Boyden chamber apparatus. Migration of smooth musc
le cells to the known chemoattractants platelet-derived growth factor,
insulin-like growth factor-1, and fibronectin (all at peak doses for
migratory activity) was attenuated by beta-estradiol (0.5 to 10 ng/ml)
in a concentration-dependent manner relative to control cells treated
with vehicle (0.01% ethanol). This response was insensitive to pretre
atment with indomethacin and was stereospecific (17 alpha-estradiol la
cked response), Like beta-estradiol, the synthetic estrogen diethylsti
lbestrol attenuated directed smooth muscle cell migration whereas the
male hormone testosterone was ineffective. Additional studies showed t
hat beta-estradiol-mediated suppression of migration was inhibited by
the anti-estrogen ICI 164,384 and tbe gene transcription inhibitor act
inomycin D. These are the first results demonstrating a reduction in d
irected smooth muscle cell migration by beta-estradiol, The mechanism
of this estrogen-mediated response appears to involve conventional est
rogen receptors.